Erlotinib and Irinotecan in Treating Patients With Advanced Solid Tumors
by on Tuesday, August 14th, 2012 | No Comments
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: erlotinib hydrochloride; Drug: irinotecan hydrochloride
Sponsors: National Cancer Institute (NCI); Mayo Clinic; National Cancer Institute (NCI)
Completed – verified August 2009
See the original post here: Erlotinib and Irinotecan in Treating Patients With Advanced Solid Tumors